Purchase Of Shares In Bausch + Lomb Corporation (BLCO) By Bausch Health Companies Inc.

As of Friday close, Bausch + Lomb Corporation’s (NYSE:BLCO) stock was down -$0.06, moving down -0.39 percent to $15.51. The average number of shares traded per day over the past five days has been 1,852,020 shares. 2 times new highs have been achieved over the past 5 days, with a $1.12 gain in that time frame. In the last twenty days, the average volume was 1,890,490, while in the previous 50 days, it was 1,299,402.

Since last month, BLCO stock retreated -2.88%. Shares of the company fell to $12.20 on 07/28/22, the lowest level in the past month. Since the beginning of this year, BLCO’s stock price has dropped by -22.45%. However, the stock has declined by -23.22% since its 52-week high.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Bausch + Lomb Corporation (BLCO) last reported insider trading activity 66 days ago on Jun 01. Bausch Health Companies Inc., the 10% Owner of the company, disposed of 4,550,357 shares for $17.05 on Jun 01. It resulted in a $77,606,339 divestment by the insider.

Valuation Metrics

Right now, Bausch + Lomb Corporation (BLCO) has a P/E ratio of about 31.02. Besides these, the trailing price-to-sales (P/S) ratio of 1.61, the price-to-book (PB) ratio of 0.76.

Financial Health

In the recent quarter, Bausch + Lomb Corporation’s quick ratio stood at 1.00, while its current ratio was 1.60, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the recent quarter was 0.31, and the total debt-to-equity ratio was 0.31. Based on annual data, BLCO earned $2.3 billion in gross profit and brought in $3.77 billion in revenue.

According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. During the quarter, the company generated $156.0 million in EBITDA. The liabilities of Bausch + Lomb Corporation were 4.03 billion at the end of its most recent quarter, and its total debt was $2.28 billion.

Technical Picture

This quick technical analysis looks at Bausch + Lomb Corporation’s (BLCO) price momentum. With a historical volatility rate of 64.03%, the RSI 9-day stood at 53.16% on 05 August.

With respect to its five-day moving average, the current Bausch + Lomb Corporation price is up by +7.78% percent or $1.12. At present, BLCO shares trade -5.60% below its 20-day simple moving average. However, the stock is currently trading approximately -3.72% below its SMA50.

Stochastic coefficient K was 76.54% and Stochastic coefficient D was 65.48%, while ATR was 1.01. Given the Stochastic reading of 81.73% for the 14-day period, the RSI (14) reading has been calculated as 50.28%. As of today, the MACD Oscillator reading stands at 0.22, while the 14-day reading stands at 0.07.

Analyst Ratings

RBC Capital Mkts launched its rating on Bausch + Lomb Corporation (NYSE: BLCO) to an Outperform in a note to investors on July 26, 2022. Bausch + Lomb Corporation (BLCO) has been rated Overweight by analysts. According to 0 brokerage firms, BLCO is a sell, and 4 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate Bausch + Lomb Corporation stock as buy, with 9 recommending it as overweight.

With a median target price of $21.50, the current consensus forecast for the stock is $17.00 – $35.00. Based on these forecasts, analysts predict Bausch + Lomb Corporation (BLCO) will achieve an average price target of $22.25.


Please enter your comment!
Please enter your name here

Hot Topics

Related Articles